Ellis Investment Partners, LLC Eli Lilly & CO Transaction History

Ellis Investment Partners, LLC

$502 Million
Q3 2024

A detailed history of Ellis Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 1,127 shares of LLY stock, worth $888,290. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,127

Previous 1,243 9.33%

Holding current value

$888,290

Previous $1.13 Million 11.29%

% of portfolio

0.2%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$772.14 - $960.02 $89,568 - $111,362	-116 Reduced 9.33%	1,127 $998,000
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $73,936 - $92,722	102 Added 8.94%	1,243 $1.13 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $40,861 - $54,667	-69 Reduced 5.7%	1,141 $887,000
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $84,030 - $99,060	-160 Reduced 11.68%	1,210 $705,000
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $125,915 - $168,363	359 Added 35.51%	1,370 $642,000
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $47,837 - $56,182	154 Added 17.97%	1,011 $347,000
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $4,823 - $5,620	-15 Reduced 1.72%	857 $313,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $889 - $1,013	3 Added 0.35%	872 $282,000
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $836 - $981	3 Added 0.35%	869 $281,000
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $704 - $874	3 Added 0.35%	866 $248,000
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $24,958 - $30,973	111 Added 14.76%	863 $238,000
Q3 2021 Oct 21, 2021	BUY	$221.6 - $272.71 $16,176 - $19,907	73 Added 10.75%	752 $173,000
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $18,235 - $23,587	101 Added 17.47%	679 $156,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $1,150 - $1,489	-7 Reduced 1.2%	578 $108,000
Q4 2020 Jan 20, 2021	SELL	$130.46 - $172.63 $21,395 - $28,311	-164 Reduced 21.9%	585 $99,000
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $292 - $338	2 Added 0.27%	749 $111,000
Q2 2020 Jul 13, 2020	BUY	$136.42 - $164.18 $409 - $492	3 Added 0.4%	747 $122,000
Q1 2020 Apr 17, 2020	BUY	$119.05 - $147.35 $16,071 - $19,892	135 Added 22.17%	744 $101,000
Q4 2019 Jan 07, 2020	BUY	$106.92 - $132.43 $213 - $264	2 Added 0.33%	609 $80,000
Q3 2019 Oct 09, 2019	BUY	$106.79 - $116.16 $56,171 - $61,100	526 Added 649.38%	607 $67,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $4.42 Million - $5.16 Million	-39,885 Reduced 99.8%	81 $9,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $4.45 Million - $5.24 Million	39,966 New	39,966 $39,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.

Account

Ellis Investment Partners, LLC Eli Lilly & CO Transaction History